Encavis Valuation

Is ECV undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ECV when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate ECV's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate ECV's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for ECV?

Key metric: As ECV is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for ECV. This is calculated by dividing ECV's market cap by their current revenue.
What is ECV's PS Ratio?
PS Ratio6.1x
Sales€457.94m
Market Cap€2.77b

Price to Sales Ratio vs Peers

How does ECV's PS Ratio compare to its peers?

The above table shows the PS ratio for ECV vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average3.6x
HRPK 7C Solarparken
2.4x2.2%€154.9m
TION Tion Renewables
4.4xn/a€149.0m
ABO clearvise
3.4x14.0%€130.0m
TION Tion Renewables
4.1xn/a€139.5m
ECV Encavis
6.1x8.1%€2.8b

Price-To-Sales vs Peers: ECV is expensive based on its Price-To-Sales Ratio (6.1x) compared to the peer average (3.6x).


Price to Sales Ratio vs Industry

How does ECV's PS Ratio compare vs other companies in the European Renewable Energy Industry?

13 CompaniesPrice / SalesEstimated GrowthMarket Cap
ECV 6.1xIndustry Avg. 2.6xNo. of Companies13PS0246810+
13 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: ECV is expensive based on its Price-To-Sales Ratio (6.1x) compared to the European Renewable Energy industry average (2.6x).


Price to Sales Ratio vs Fair Ratio

What is ECV's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ECV PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio6.1x
Fair PS Ratio3x

Price-To-Sales vs Fair Ratio: ECV is expensive based on its Price-To-Sales Ratio (6.1x) compared to the estimated Fair Price-To-Sales Ratio (3x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst ECV forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€17.16
€17.85
+4.0%
5.2%€20.30€17.50n/a8
Nov ’25€17.11
€17.87
+4.4%
4.9%€20.30€17.50n/a9
Oct ’25€17.16
€17.47
+1.8%
7.9%€20.30€13.90n/a11
Sep ’25€17.00
€17.47
+2.8%
7.9%€20.30€13.90n/a11
Aug ’25€17.07
€17.47
+2.4%
7.9%€20.30€13.90n/a11
Jul ’25€16.90
€17.47
+3.4%
7.9%€20.30€13.90n/a11
Jun ’25€17.14
€17.48
+2.0%
7.6%€20.30€13.90n/a12
May ’25€16.90
€17.60
+4.1%
7.9%€20.30€13.90n/a12
Apr ’25€16.86
€17.68
+4.9%
8.1%€20.30€13.90n/a12
Mar ’25€11.18
€17.69
+58.2%
28.0%€28.00€11.50n/a12
Feb ’25€12.88
€18.69
+45.1%
25.6%€28.00€11.50n/a12
Jan ’25€15.59
€19.25
+23.5%
22.2%€28.00€12.00n/a12
Dec ’24€13.81
€19.25
+39.4%
22.2%€28.00€12.00€17.1212
Nov ’24€12.26
€20.82
+69.9%
20.3%€28.00€12.00€17.1111
Oct ’24€13.33
€21.70
+62.9%
15.4%€28.00€17.00€17.1610
Sep ’24€13.80
€21.96
+59.2%
15.2%€28.00€17.00€17.0011
Aug ’24€15.16
€22.05
+45.5%
14.8%€28.00€17.00€17.0711
Jul ’24€15.03
€22.33
+48.6%
14.3%€28.00€17.00€16.9011
Jun ’24€15.29
€22.33
+46.1%
14.3%€28.00€17.00€17.1411
May ’24€15.68
€22.41
+43.0%
14.1%€28.00€17.00€16.9011
Apr ’24€15.78
€22.38
+41.8%
14.2%€28.00€17.00€16.8611
Mar ’24€17.42
€22.72
+30.5%
15.7%€28.00€17.00€11.1810
Feb ’24€17.99
€22.42
+24.6%
16.6%€28.00€17.00€12.889
Jan ’24€18.49
€23.73
+28.4%
13.7%€28.60€19.00€15.599
Dec ’23€20.23
€24.18
+19.5%
15.6%€30.00€19.00€13.819

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies